Tom Ceska
34 works · 1,398 citations · h-index 18
Top works
- Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors
- Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
- Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A
- Author Correction: Cycloalkane-modified amphiphilic polymers provide direct extraction of membrane proteins for CryoEM analysis
- Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
- Crystal structure of the adenosine A 2A receptor bound to an antagonist reveals a potential allosteric pocket
- Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
- Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF
- Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-life
- GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014
- Direct observation of DNA threading in flap endonuclease complexes
- Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines
- Cryo-EM in drug discovery
- Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
- Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping
- A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF
- Cycloalkane-modified amphiphilic polymers provide direct extraction of membrane proteins for CryoEM analysis
- Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo
- P150 DETAILING THE NOVEL STRUCTURE OF THE BIOPHARMACEUTICAL CERTOLIZUMAB PEGOL
- Discovery and Characterization of a Novel Series of Chloropyrimidines as Covalent Inhibitors of the Kinase MSK1